Nextar Chempharma Solutions
Contract Drug Development and Manufacturing
Company Overview
Snapshot
Founded in July 2007 by Orna Dreazen, Nextar Chempharma Solutions operates with 11–50 employees. The company has raised $370,000 across one funding round. In March 2025, Nextar Chempharma Solutions was acquired by Nextage Therapeutics.
Business overview
Nextar Chempharma Solutions specializes in contract drug development, manufacturing, and medical device development within the Health Tech & Life Sciences sector. The company's core technology includes its proprietary Brain Targeted Liposomes (BTLS) platform, designed to facilitate targeted delivery of drugs across the blood-brain barrier for brain-specific delivery of therapeutic agents. Nextar serves the pharmaceutical industry, focusing on CNS disorders and generic drugs.
Strategic signal
In September 2023, Nextar Chempharma Solutions announced positive final results from a mouse study demonstrating the efficacy of its BTLS platform in treating glioblastoma, a type of brain cancer. This preclinical validation signals significant potential for the company's drug delivery technology in addressing challenging neurological conditions and could attract further interest in its therapeutic applications.
Company Intelligence Q&A
- What is Nextar Chempharma Solutions' primary focus?
- Nextar Chempharma Solutions specializes in contract drug development and manufacturing, particularly focusing on its Brain Targeted Liposomes (BTLS) platform for targeted drug delivery across the blood-brain barrier.
- When was Nextar Chempharma Solutions acquired?
- Nextar Chempharma Solutions was acquired by Nextage Therapeutics in March 2025.
- What was a significant development regarding Nextar's BTLS platform?
- In September 2023, Nextar Chempharma Solutions reported positive final results from a mouse study demonstrating the efficacy of its BTLS platform in treating glioblastoma.
- What was the total capital raised by Nextar Chempharma Solutions?
- Nextar Chempharma Solutions raised a total of $370,000 across one funding round.
- What is the employee size of Nextar Chempharma Solutions?
- Nextar Chempharma Solutions operates with 11–50 employees.